Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (hereinafter referred to as Listing Regulations ), we wish to inform that M/s. LatentView Analytics Corporation (Incorporated in New Jersey), a Material & Wholly Owned Subsidiary of the Company has executed a Simple Agreement for Future Equity Notes (SAFE Notes) on April 01, 2026 for a strategic investment of USD 3,000,000 (Three Million Dollars) in M/s. Healtheon AI INC. (a Delaware Corporation) ( Target Entity ), specialized in Agentic-AI framework for Revenue Cycle Management ( RCM ) services for healthcare providers in the US.
LATENTVIEW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
LatentView Analytics' wholly-owned US subsidiary, LatentView Analytics Corporation, has entered into a SAFE (Simple Agreement for Future Equity) agreement to invest USD 3 million in Healtheon AI INC., a Delaware corporation incorporated on March 20, 2026. Healtheon AI specializes in an Agentic-AI framework for Revenue Cycle Management services targeting US healthcare providers. The investment is entirely in cash, with conversion to preferred equity triggered by future financing events or other agreed conditions. No shares or voting control are acquired immediately. The deal is not a related party transaction and requires no regulatory approvals. Completion is targeted on or before April 7, 2026.
The investment gives LatentView a foothold in the AI-powered healthcare RCM space, a new vertical outside its core analytics business, through a low-commitment SAFE structure. No immediate financial impact expected, but it signals strategic diversification into high-growth AI services.